CDK1 and lung carcinoma: In addition, silencing of miR-21 in A549 human lung cancer cells increased oxidative damage and the cell cycle was blocked at the G0/G1 phase by downregulation of CDK1, thus reversing multidrug resistance of lung cancer cells [46].